Safety and efficacy of pazopanib in heavily pretreated and treatment-naive patients with metastatic renal cell carcinoma (mRCC): A single center experience of the Medical University of Vienna, Austria.

被引：0
|
作者：
Schmidinger, Manuela
Bojic, Marija
Vogl, Ursula Maria
Klingler, Christoph
Kramer, Gero
Zielinski, Christoph
机构：
[1] Med Univ Vienna, Vienna, Austria
[2] Med Univ Vienna, Dept Med 1, Div Clin Oncol, Vienna, Austria
[3] Med Univ Vienna, Ctr Canc, Vienna, Austria
[4] Dept Med 1, Div Oncol, Vienna, Austria
[5] Dept Urol, Vienna, Austria
[6] Med Univ Vienna, Ctr Comprehens Canc, Vienna, Austria
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2012年 / 30卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e15090
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Safety and efficacy of axitinib in pretreated patients with metastatic renal cell carcinoma: A single center experience of the Medical University of Vienna, Austria
    Vogl, Ursula Maria
    Ponhold, Lothar
    Locker, Gottfried J.
    Zielinski, Christoph
    Klingler, Christoph
    Kramer, Gero
    Schmidinger, Manuela
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [2] A phase II study of the efficacy and safety of sunitinib in treatment-naive and pretreated Japanese patients (pts) with metastatic renal cell carcinoma (mRCC)
    Uemura, H.
    Shinohara, N.
    Naito, S.
    Akaza, H.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [3] Safety and efficacy of temsirolimus in heavily pretreated patients with metastatic renal cell carcinoma
    Lamm, Wolfgang
    Vogl, Ursula Maria
    Bojic, Marija
    Zielinski, Christoph
    Klingler, Christoph
    Kramer, Gero
    Schmidinger, Manuela
    ACTA ONCOLOGICA, 2012, 51 (01) : 101 - 106
  • [4] Efficacy and safety of Pazopanib in the treatment of metastatic renal cell carcinoma
    Marmesat Rodas, B.
    Marquez Fernandez, E.
    Quesada Sanz, M. P.
    Guerra Estevez, D.
    Villanueva Jimenez, P.
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2016, 38 (02) : 572 - 572
  • [5] Efficacy and Safety of Pazopanib in Patients With Metastatic Renal Cell Carcinoma
    Hutson, Thomas E.
    Davis, Ian D.
    Machiels, Jean-Pascal H.
    De Souza, Paul L.
    Rottey, Sylvie
    Hong, Bao-fa
    Epstein, Richard J.
    Baker, Katherine L.
    McCann, Lauren
    Crofts, Theresa
    Pandite, Lini
    Figlin, Robert A.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (03) : 475 - 480
  • [6] Active surveillance and deferred medical treatment (ASDT) in metastatic renal cell carcinoma (mRCC): Update of a single center experience and efficacy of medical treatment.
    Ivanyi, Philipp
    Tiemann, Maria-Luisa
    Granwald, Viktor
    Eggers, Hendrik
    Ganser, Arnold
    Reuter, Christoph
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [7] Efficacy and safety of pazopanib as a subsequent treatment after failure of other targeted agents in patients with metastatic renal cell carcinoma (mRCC).
    Tan, Jiahuai
    Heilbrun, Lance K.
    Fontana, Joseph A.
    Smith, Daryn
    Heath, Elisabeth I.
    Baranowski, Karen
    Vaishampayan, Ulka N.
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (05)
  • [8] Active surveillance and deferred medical treatment (ASDT) in metastatic renal cell carcinoma (mRCC): Update of a single center experience
    Tiemann, M. -L.
    Gruenwald, V.
    Eggers, H.
    Ganser, A.
    Reuter, C.
    Ivanyi, P.
    ONCOLOGY RESEARCH AND TREATMENT, 2018, 41 : 80 - 80
  • [9] Efficacy and Safety of Pazopanib in Patients With Metastatic Renal Cell Carcinoma Editorial Comment
    Marshall, Fray F.
    JOURNAL OF UROLOGY, 2010, 184 (04): : 1303 - 1303
  • [10] Nivolumab in metastatic renal cell carcinoma (mRCC) patients: a real world single-center experience
    Ratta, R.
    Grassi, P.
    Verzoni, E.
    Mennitto, A.
    de Braud, F.
    Procopio, G.
    ANNALS OF ONCOLOGY, 2016, 27
12345